HIV/Hepatitis External Quality Assessment

The RIQAS HIV/Hepatitis EQA programme is designed to monitor the performance of tests used to detect HIV/Hepatitis virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for qualitative methods of analysis.

  • Liquid ready-to-use
  • 100% human plasma
  • Quarterly reporting (5 samples per quarterly distribution)
  • Submit results and view reports online via RIQASNet
  • Suitable for both quantitative and qualitative methods of analysis
Not accredited to ISO/IEC 17043
Cat No Kit Size Frequency Cycle Start Analytes
RQ9151 Expand 1.8ml (samples shipped 4 times per year) Quarterly reporting
(1 x 12 month cycle)
June 10


  • Anti-HIV-1
  • Anti-HCV
  • Anti-HTLV-II
  • HBsAg
  • Anti-HIV-2
  • Anti-HBc
  • Anti-HTLV-1&2 (combined)
  • Anti-HIV-1&2 (combined)
  • Anti-HTLV-I
  • Anti-CMV